| Literature DB >> 30100813 |
Verena Kurz1, Andreas Orland2, Kinga Posadzy3.
Abstract
We investigate in a laboratory experiment whether procedural fairness concerns affect how well individuals are able to solve a coordination problem in a two-player Volunteer's Dilemma. Subjects receive external action recommendations, either to volunteer or to abstain from it, in order to facilitate coordination and improve efficiency. We manipulate the fairness of the recommendation procedure by varying the probabilities of receiving the disadvantageous recommendation to volunteer between players. We find evidence that while recommendations improve overall efficiency regardless of their implications for expected payoffs, there are behavioural asymmetries depending on the recommendation: advantageous recommendations are followed less frequently than disadvantageous ones and beliefs about others' actions are more pessimistic in the treatment with recommendations inducing unequal expected payoffs.Entities:
Keywords: Coordination; Correlated equilibrium; Experiment; Procedural fairness; Recommendations; Volunteer’s Dilemma
Year: 2017 PMID: 30100813 PMCID: PMC6061030 DOI: 10.1007/s10683-017-9540-5
Source DB: PubMed Journal: Exp Econ ISSN: 1386-4157
Payoff matrix of the Volunteer’s Dilemma
| Player 2 | ||
|---|---|---|
|
|
| |
| Player 1 | ||
| |
|
|
| |
| 0, 0 |
The experimental calibration of the Volunteer’s Dilemma
| Player 2 | ||
|---|---|---|
|
|
| |
| Player 1 | ||
| | 5, 5 | 5, 10 |
| | 10, 5 | 0, 0 |
Summary of the experimental design
| Treatment | Recommendation | Expected payoff player 1 | Expected payoff player 2 |
|---|---|---|---|
|
| None | 5 | 5 |
|
|
| 7.5 | 7.5 |
|
| |||
|
|
| 9.5 | 5.5 |
|
|
Key variables in all treatments and pairwise comparisons
| Means |
| |||||
|---|---|---|---|---|---|---|
|
|
|
|
|
|
| |
| Contribution rate | 0.614 | 0.577 | 0.580 | 0.172 | 0.754 | 0.302 |
| Coordination rate | 0.447 | 0.657 | 0.619 | <0.001 | <0.001 | 0.553 |
| Coordination rate* | 0.471 | 0.657 | 0.617 | <0.001 | 0.002 | 0.783 |
| Following rate | – | 0.787 | 0.754 | – | – | 0.533 |
| Earnings | 5.308 | 6.171 | 5.991 | <0.001 | 0.005 | 0.134 |
| Earnings* | 5.428 | 6.167 | 5.981 | <0.001 | 0.355 | 0.069 |
Pairwise comparisons use Wilcoxon rank-sum tests. For tests on following rates and and earnings, data was collapsed at the subject level ( in each treatment). Since coordination rates are the same for both types of players, in each treatment
* Values based on all possible pairings
Fig. 1Outcomes played across treatments with MNE and CE predictions and 95% confidence intervals
Fig. 2Following rates by player type in treatments CD50 and CD90 with 95% confidence intervals
Fig. 3Earnings by player type in all treatments with 95% confidence intervals
Linear probability model on following the recommendations
| Model 1 coef./SE | Model 2 coef./SE | Model 3 coef./SE | Model 4 coef./SE | |
|---|---|---|---|---|
| Treatment | ||||
| CD90 | −0.109* | −0.036 | 0.028 | −0.001 |
| (0.059) | (0.058) | (0.056) | (0.073) | |
| Type of player | ||||
| Player 2 | −0.030 | −0.030 | −0.006 | −0.037 |
| (0.048) | (0.048) | (0.040) | (0.040) | |
| Treatment*Type of player | ||||
| CD90 × player 2 | 0.154** | 0.020 | −0.020 | 0.007 |
| (0.074) | (0.068) | (0.056) | (0.057) | |
| Advantageous recomm. | ||||
| Yes | −0.154*** | −0.154*** | −0.154*** | |
| (0.046) | (0.046) | (0.046) | ||
| Treatment*Advantageous recomm. | ||||
| CD90 × yes | −0.013 | −0.013 | −0.013 | |
| (0.071) | (0.071) | (0.071) | ||
| Others follow | ||||
| Yes | 0.288*** | 0.275*** | ||
| (0.034) | (0.035) | |||
| Constant | 0.802*** | 0.879*** | 0.639*** | 0.764*** |
| (0.033) | (0.035) | (0.044) | (0.165) | |
| Control variables | No | No | No | Yes |
| Adj. R2 | 0.012 | 0.036 | 0.128 | 0.142 |
| Number of cases | 4320 | 4320 | 4320 | 4320 |
Control variables include round, session dummies, female dummy, economics/business student dummy, below-average risk aversion dummy, Locus of Control, Big Five
Significance levels * 10%, ** 5%, *** 1%. Standard errors clustered at the subject level
OLS regressions on earnings
| Model 1 coef./SE | Model 2 coef./SE | Model 3 (CD50&CD90) coef./SE | Model 4 (CD50&CD90) coef./SE | Model 5 (CD50&CD90) coef./SE | |
|---|---|---|---|---|---|
| Treatment | |||||
| CD50 | 0.972*** | 0.995*** | |||
| (0.18) | (0.29) | ||||
| CD90 | 1.861*** | 1.730*** | 0.889*** | 1.149*** | 1.146*** |
| (0.21) | (0.29) | (0.24) | (0.14) | (0.19) | |
| Type of player | |||||
| Player 2 | 0.338** | 0.310** | 0.120 | 0.191 | 0.121 |
| (0.17) | (0.15) | (0.21) | (0.13) | (0.14) | |
| Treatment*Type of player | |||||
| CD50 × player 2 | −0.218 | −0.331 | |||
| (0.27) | (0.26) | ||||
| CD90 × player 2 | −2.356*** | −2.336*** | −2.139*** | −2.504*** | −2.414*** |
| (0.26) | (0.25) | (0.29) | (0.18) | (0.19) | |
| Follow recommendations | |||||
| Yes | 2.378*** | 2.344*** | |||
| (0.13) | (0.14) | ||||
| Constant | 5.139*** | 5.186*** | 6.111*** | 4.204*** | 4.187*** |
| (0.10) | (0.57) | (0.15) | (0.14) | (0.46) | |
| Control variables | No | Yes | No | No | Yes |
| Adj. R2 | 0.050 | 0.059 | 0.055 | 0.160 | 0.161 |
| Number of cases | 6480 | 6480 | 4320 | 4320 | 4320 |
Control variables include round, session dummies, gender, economics/business student dummy, below-average risk aversion dummy, Locus of Control, Big Five
Significance levels * 10%, ** 5%, *** 1%. Standard errors clustered at the subject level
Following rates contingent on subjects’ beliefs and player type in CD50 and CD90
| Others follow | CD50 | Wilcoxon rank-sum | CD90 | Wilcoxon rank-sum | ||
|---|---|---|---|---|---|---|
| Type of player | Type of player | |||||
| Player 1 | Player 2 | Player 1 (advantaged) | Player 2 (disadvantaged) | |||
| Yes | 0.841 | 0.851 | 0.636 | 0.873 | 0.854 | 0.495 |
|
|
|
|
| |||
| No | 0.606 | 0.537 | 0.120* | 0.410 | 0.742 | 0.001 |
|
|
|
|
| |||
| Wilcoxon rank-sum | 0.008 | <0.001 | <0.001 | 0.050 | ||
* p-value based on the exact statistic, since the number of observations in two groups is below 25
Fig. 4Following rates contingent on subjects’ beliefs and type of recommendation in CD50 and CD90 with 95% confidence intervals